missing translation for 'onlineSavingsMsg' Learn More
Catalog No. 12012100UG
Change view
Click to view available options
Quantity:
100 μg
25 μg
250 μg
5 μg
500 μg
1 mg
6 product options available for selection
Product selection table with 6 available options. Use arrow keys to navigate and Enter or Space to select. Catalog No. Quantity 12012100UG 100 μg 120121MG 1 mg 12012250UG 250 μg 1201225UG 25 μg 12012500UG 500 μg 120125UG 5 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 6 options available.
6 options
Catalog No. 12012100UG Supplier GibcoTM Supplier No. 12012100UG
$1,086.00 / Each
Add to Cart
Add to Cart
Description Specifications Product Suggestions Videos Documents Certificates Safety and Handling Safety Services Promotions
Description
Recombinant Protein
Recombinant Human Myostatin-Propeptide is a 27.8 kDa protein consisting of 244 amino acid residues. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
Mature myostatin is obtained by proteolytic processing of a biologically-inactive precursor protein, which contains an N-terminal propeptide of 243 amino acid residues. Myostatin-Propeptide exhibits high binding affinity for myostatin, and has been shown to be a potent inhibitor of myostatin. Over-expression of myostatin-propeptide in mice resulted in large increases (up to 200%) in skeletal muscle mass, similar to those observed in myostatin knockout mice.
Specifications
Specifications
Accession Number O14793 For Use With (Application) Control, Bioactivity Formulation Protein with no preservative Gene ID (Entrez) 2660 Molecular Weight (g/mol) 27.8 kDa Name Human Myostatin Propeptide Purification Method Purified Quantity 100 μg Source E. coli Storage Requirements -20°C Regulatory Status RUO Endotoxin Concentration <1 EU/μg Gene Alias Myostatin Common Name pro-Myostatin Gene Symbol MSTN Biological Activity Determined by its ability to neutralize the Myostatin inhibitory effect of murine MPC-11 cells. The expected ED50 is 0.01-0.04 ug/ml in the presence of 50 ng/ml Myostatin. Product Type Protein Conjugate Unconjugated Recombinant Recombinant Sequence MNENSEQKEN VEKEGLCNAC TWRQNTKSSR IEAIKIQILS KLRLETAPNI SKDVIRQLLP KAPPLRELID QYDVQRDDSS DGSLEDDDYH ATTETIITMP TESDFLMQVD GKPKCCFFKF SSKIQYNKVV KAQLWIYLRP VETPTTVFVQ ILRLIKPMKD GTRYTGIRSL KLDMNPGTGI WQSIDVKTVL QNWLKQPESN LGIEIKALDE NGHDLAVTFP GPGEDGLNPF LEVKVTDTPK RSRR Content And Storage -20°C Activity Determined by its ability to neutralize the Myostatin inhibitory effect of murine MPC-11 cells. The expected ED50 is 0.01-0.04 ug/ml in the presence of 50 ng/ml Myostatin. Expression System E. coli Form Lyophilized Purity or Quality Grade ≥ 98% by SDS-PAGE gel and HPLC analyses. Show More Show Less